Changliang Yang
- Oncology top 10%
- Lung Cancer Research Studies 10
- Cancer Immunotherapy and Biomarkers 4
- Inflammatory Biomarkers in Disease Prognosis 2
- Neutropenia and Cancer Infections 1
-
- Lung Cancer Treatments and Mutations 6
-
- Cancer therapeutics and mechanisms 3
-
- Neuroendocrine Tumor Research Advances 2
-
- Gyrotron and Vacuum Electronics Research 1
- Co-authors
- Jingjing LiuShuang ZhangYing ChengLixia MaYing LiuShuang LiJing ZhuYing Wang
- Journals
- SHILAP Revista de lepidopterología (1 paper)Frontiers in Immunology (1 paper)Lung Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Changliang Yang
14 papers receiving 321 citations
Peers
Comparison fields: 5 of 57
- Oncology 249
- Pulmonary and Respiratory Medicine 120
- Cancer Research 54
- Immunology 34
- Internal Medicine 6
Countries citing papers authored by Changliang Yang
This map shows the geographic impact of Changliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changliang Yang more than expected).
Fields of papers citing papers by Changliang Yang
This network shows the impact of papers produced by Changliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changliang Yang. The network helps show where Changliang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changliang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 21 | |
| 5 | 2020 | 10 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 231 | |
| 9 | 2019 | 7 | |
| 10 | 2018 | 3 | |
| 11 | 2017 | 11 | |
| 12 | 2017 | 1 | |
| 13 | 2016 | 2 | |
| 14 | 2015 | 0 | |
| 15 | [Association of UGT1A1 (*28, *60 and * 93) polymorphism with the adverse reactions of irinotecan chemotherapy in extensive stage small cell lung cancer]. | 2015 | 2 |
About Changliang Yang
Changliang Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 15 papers that have together received 326 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer therapeutics and mechanisms (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Gyrotron and Vacuum Electronics Research (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Oncology (249 citations), Pulmonary and Respiratory Medicine (120 citations) and Cancer Research (54 citations). Changliang Yang has collaborated with scholars based in China and United States. Frequent co-authors include Jingjing Liu, Shuang Zhang, Ying Cheng, Lixia Ma, Ying Liu, Shuang Li, Jing Zhu, Ying Wang, Ying Xin and Ying Cheng. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.